Isoflavone effects on insulin like growth factors and breast cancer
An increased concentration of insulin-like growth factor-1 (IGF-1) is recognized to be an independent risk factor for pre-menopausal breast cancer. Tamoxifen is thought to initially reduce IGF-1 concentrations and increase levels of the IGF binding proteins 1 and 3. Isoflavones are oestrogen-like pl...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.497969 |